Prognostic Value of Pan-Immune-inflammation Value and Body Mass Index in Geriatric Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors As First Line Treatment. A Single-Center Retrospective Study.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY(2023)
关键词
body mass index (BMI),bio- markers,geriatric,tyrosine kinase inhib- itors (TKIs),metastatic renal cell carcino- ma (mRCC),pan-immune -inflammation value (PIV)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要